<DOC>
	<DOCNO>NCT02171819</DOCNO>
	<brief_summary>This first-in-human study safety immunogenicity A/H5N1 inactivate whole cell vaccine manufacture IVAC Vietnam give two injection two dos ( low high ) compare placebo 76 healthy adult subject Vietnam .</brief_summary>
	<brief_title>Influenza A/H5N1 Vaccine Clinical Trial ( IVACFLU-A/H5N1 ) - Phase 1</brief_title>
	<detailed_description>This phase 1 , double blind , randomize , placebo-controlled study . Seventy-six healthy male female adult , 18 30 year age , enrol trial . Subjects randomize one three treatment allocation : 32 subject 7.5 mcg/dose vaccine ( low dose ) , 32 subject 15 mcg/dose vaccine ( high dose ) 12 subject placebo . This sample size select enable least 30 evaluable subject group receive active vaccine . The study utilize `` block randomization '' assure balance 8:8:3 vaccine placebo subject enrol . The study double blind , mean study subject , investigator , sponsor unaware treatment allocate subject clinical trial database declare final lock . Since first-in-human study , injection study product sequential stagger safety evaluation sentinel cohort 19 subject remain 57 study subject 1st 2nd dos study . A sentinel group 19 participant ' enrollment vaccination precede remainder study group approximately 2-3 week . Product administration injection vaccine placebo sequential stagger .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>Male female adult 18 30 year age enrollment visit . Literate willing provide write informed consent . Healthy adult , establish medical history screening evaluation , include physical examination . Capable willing complete diary card willing return followup visit . For female , willing utilize reliable birth control measure ( intrauterine device , hormonal contraception , condom ) Day 42 visit Known hypersensitivity ( vaccine egg ) Participating research study History asthma Chronic use immunosuppressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Avian</keyword>
	<keyword>H5N1</keyword>
	<keyword>Vaccine</keyword>
</DOC>